February 24, 2020 11:46 AM EST

Eli Lilly scores expanded MACE label for Trulicity; Gilead's CAR-T Yescarta gets in China review line

→ The FDA has expanded the label for Eli Lilly‘s type 2 diabetes drug Trulicity, saying that it is now

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Eli Lil­ly scores ex­pand­ed MACE la­bel for Trulic­i­ty; Gilead­'s CAR-T Yescar­ta gets in Chi­na re­view line